Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Rokt $300 million merger with mParticle
We are advising Rokt on the transaction
Deutsche Bank $1.75 billion notes offerings
The offerings included fixed-to-floating-rate and floating-rate eligible liabilities notes
UBS $1.25 billion senior notes offering
The investment-grade notes are due 2028
SP Group Treasury GMTN update and $700 million notes offering
The notes are due 2029
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
Toyota Motor Credit $2.6 billion notes offering
We advised Toyota Motor Credit on the SEC-registered notes offering
The Baldwin Group $935 million credit facilities financing
We advised the borrower on the refinancing and amendment
CRH $3 billion guaranteed notes offering
The investment-grade notes are due 2030, 2035 and 2055
iHeart comprehensive out-of-court debt restructuring
We advised an ad hoc group of noteholders and term loan lenders on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction